Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
作者信息
Griggs Jennifer J, Mangu Pamela B, Temin Sarah, Lyman Gary H
机构信息
University of Michigan, Ann Arbor MI; American Society of Clinical Oncology, Alexandria, VA; and Duke University, Durham, NC.
出版信息
J Oncol Pract. 2012 Jul;8(4):e59-e61. doi: 10.1200/JOP.2012.000623.
Abstract
摘要
相似文献
1
Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
J Oncol Pract. 2012 Jul;8(4):e59-e61. doi: 10.1200/JOP.2012.000623.
2
Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
J Clin Oncol. 2015 Jun 20;33(18):2100-5. doi: 10.1200/JCO.2014.59.2360. Epub 2015 May 5.
3
Clarifying the American Society of Clinical Oncology practice guideline for chemotherapy dosing for obese adults.
J Clin Oncol. 2012 Nov 1;30(31):3897; author reply 3898-9. doi: 10.1200/JCO.2012.44.1626. Epub 2012 Sep 10.
4
Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
Cancer Chemother Pharmacol. 2013 Jan;71(1):175-82. doi: 10.1007/s00280-012-1994-8. Epub 2012 Oct 12.
5
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
J Clin Oncol. 2002 Oct 1;20(19):4083-107. doi: 10.1200/JCO.2002.07.177.
6
Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies.
Gynecol Oncol. 2015 Jul;138(1):201-6. doi: 10.1016/j.ygyno.2015.04.002. Epub 2015 Apr 12.
7
Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.
J Clin Oncol. 1999 Nov;17(11):3676-81. doi: 10.1200/JCO.1999.17.11.3676.
8
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
J Clin Oncol. 1999 Oct;17(10):3333-55. doi: 10.1200/JCO.1999.17.10.3333.
9
Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA).
Cancer Treat Rev. 2009 Feb;35(1):69-78. doi: 10.1016/j.ctrv.2008.07.005. Epub 2008 Oct 14.
10
American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.
J Clin Oncol. 1994 Nov;12(11):2471-508. doi: 10.1200/JCO.1994.12.11.2471.
引用本文的文献
1
Anti-cancer efficacy of novel lonidamine derivatives: Design, synthesis, in vitro, in vivo, and computational studies targeting hexokinase-2.
Eur J Med Chem. 2025 Oct 15;296:117890. doi: 10.1016/j.ejmech.2025.117890. Epub 2025 Jun 19.
2
Obese patients with malignant tumor: a case series and literature review.
Discov Oncol. 2025 Jun 6;16(1):1020. doi: 10.1007/s12672-025-02689-8.
3
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.
Blood Adv. 2023 Sep 26;7(18):5234-5245. doi: 10.1182/bloodadvances.2023009976.
4
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management.
Cancers (Basel). 2023 Jan 12;15(2):485. doi: 10.3390/cancers15020485.
5
Chemotherapy Dose Shapes the Expression of Immune-Interacting Markers on Cancer Cells.
Cell Mol Bioeng. 2022 Oct 1;15(6):535-551. doi: 10.1007/s12195-022-00742-y. eCollection 2022 Dec.
6
Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016.
JAMA Netw Open. 2022 Oct 3;5(10):e2234445. doi: 10.1001/jamanetworkopen.2022.34445.
7
The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer.
Breast Cancer Res Treat. 2022 Oct;195(3):325-331. doi: 10.1007/s10549-022-06681-6. Epub 2022 Aug 16.
8
Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative Review.
Curr Med Chem. 2023;30(9):1003-1028. doi: 10.2174/0929867329666220806140204.
9
Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
Cancer. 2022 Jun 1;128(11):2174-2181. doi: 10.1002/cncr.34173. Epub 2022 Mar 14.
10
Incidence of trastuzumab-induced cardiotoxicity and impact of body mass index in patients with breast cancer: Results from a Saudi tertiary cancer center.
Mol Clin Oncol. 2022 Apr;16(4):78. doi: 10.3892/mco.2022.2511. Epub 2022 Feb 8.
本文引用的文献
1
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
J Clin Oncol. 2012 May 1;30(13):1553-61. doi: 10.1200/JCO.2011.39.9436. Epub 2012 Apr 2.
Zotero 插件